The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Bonello William since 2019.
This trader's CIK number is 1454941.
At the time of last reporting, Bonello William was the Chief Financial Officer of Neogenomics Inc. (stock ticker symbol NEO).
Also see all insider trading activities at Neogenomics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | NEO | 0 | $0 | 3,209 | $58,692 | 10,727 | $80,667 |
| 2021 | NEO | 0 | $0 | 25,000 | $928,250 | 50,000 | $388,749 |
| 2020 | NEO | 0 | $0 | 30,000 | $1,223,820 | 30,000 | $235,289 |
| 2019 | NEO | 0 | $0 | 84,403 | $1,729,362 | 84,403 | $650,062 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-04-28 | NEO | Option Ex | 5,727 | 7.52 | 43,067 |
| 2022-03-08 | NEO | Option Ex | 5,000 | 7.52 | 37,600 |
| 2022-03-07 | NEO | Sale | 3,209 | 18.29 | 58,692 |
| 2021-11-30 | NEO | Option Ex | 25,000 | 7.52 | 188,000 |
| 2021-11-24 | NEO | Option Ex | 25,000 | 8.03 | 200,749 |
| 2021-11-24 | NEO | Sale | 25,000 | 37.13 | 928,250 |
| 2020-12-02 | NEO | Option Ex | 8,000 | 8.03 | 64,239 |
| 2020-12-02 | NEO | Sale | 8,000 | 46.80 | 374,400 |
| 2020-08-03 | NEO | Sale | 22,000 | 38.61 | 849,420 |
| 2020-08-03 | NEO | Option Ex | 22,000 | 7.78 | 171,050 |
| 2019-08-28 | NEO | Option Ex | 17,000 | 7.52 | 127,840 |
| 2019-08-28 | NEO | Sale | 17,000 | 24.83 | 422,110 |
| 2019-05-06 | NEO | Sale | 7,200 | 23.53 | 169,416 |
| 2019-05-06 | NEO | Option Ex | 7,200 | 7.52 | 54,144 |
| 2019-02-26 | NEO | Option Ex | 60,203 | 7.78 | 468,078 |
| 2019-02-26 | NEO | Sale | 60,203 | 18.90 | 1,137,836 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bonello William (Chief Financial Officer of Neogenomics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.